Home » Symetis Completes Enrollment, Obtains Positive Results
Symetis Completes Enrollment, Obtains Positive Results
Symetis SA, a private Swiss company developing new transcatheter aortic valve implantation systems, announced Thursday the completion of patient enrollment in its Acurate TAT first-in-man clinical study and positive preliminary results.
One News Page
One News Page
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May